Seeing Is Believing
Currently out of the existing stock ratings of Caroline Palomeque, 9 are a BUY (81.82%), 2 are a HOLD (18.18%).
Analyst Caroline Palomeque, carries an average stock price target met ratio of 28.57% that have a potential upside of 50.35% achieved within 593 days. Previously, Caroline Palomeque worked at MAXIM GROUP.
Caroline Palomeque’s has documented 21 price targets and ratings displayed on 7 stocks. The coverage was on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on DARE, Dare Bioscience at 04-Sep-2025.
Analyst best performing recommendations are on AVXL (ANAVEX LIFE SCIENCES CORP).
The best stock recommendation documented was for AVXL (ANAVEX LIFE SCIENCES CORP) at 5/16/2018. The price target of $7 was fulfilled within 904 days with a profit of $4.56 (186.89%) receiving and performance score of 2.07.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Nov-2015
$24
$21.38 (816.03%)
$24
3 months 26 days ago
(31-Mar-2026)
5/13 (38.46%)
$20.93 (681.76%)
1510
Buy Since 16-Mar-2020
5 months 17 days ago
(10-Feb-2026)
3/17 (17.65%)
$32.22 (329.45%)
204
Buy Since 29-Jul-2021
$15
9 months 3 days ago
(24-Oct-2025)
0/9 (0%)
$8.18 (119.94%)
Buy Since 24-Sep-2021
$28
$25.05 (849.15%)
$35
3 years 5 months 18 days ago
(09-Feb-2023)
0/4 (0%)
$17.59 (168.97%)
Buy Since 26-Feb-2020
$11
$8.05 (272.88%)
3 years 7 months 21 days ago
(06-Dec-2022)
3/4 (75%)
$2.62 (31.26%)
139
What Year was the first public recommendation made by Caroline Palomeque?